causal
Off-patent drugs underexplored due to market failure
There is little incentive to explore cheap, off-patent small molecules (like hydroxychloroquine) because no one owns the intellectual property, a market-failure problem the NIH could in principle solve; questions like hydroxychloroquine's efficacy could be answered with a simple trial if anyone had the incentive to fund it.
causalpending
Speaker
Jay BhattacharyaEvidence Quote
“it's a market failure problem, right? Because no one owns that intellectual property.”
Created: 6/13/2026, 12:19:28 AM
Your notes
Loading notes...